| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918599 | Radiotherapy and Oncology | 2014 | 5 Pages |
Abstract
We conclude that the oral administration of EGCG is feasible, safe and effective. The phase II recommended concentration is 440 μmol/L.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hanxi Zhao, Wanqi Zhu, Peng Xie, Huiqin Li, Xiqin Zhang, Xiaorong Sun, Jinming Yu, Ligang Xing,